- Home
- SOPH
SOPH
SOPHiA GENETICS SA
as 04-18-2025 1:43pm EST
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
| Founded: | 2011 | Country: | Switzerland |
| Employees: | N/A | City: | N/A |
| Market Cap: | 206.6M | IPO Year: | 2021 |
| Target Price: | $6.50 | AVG Volume (30 days): | 36.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.95 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.60 - $6.28 | Next Earning Date: | 05-06-2025 |
| Revenue: | $65,173,000 | Revenue Growth: | 4.49% |
| Revenue Growth (this year): | 14.83% | Revenue Growth (next year): | 22.79% |
Latest SOPHiA GENETICS SA News
SOPH Breaking Stock News: Dive into SOPH Ticker-Specific Updates for Smart Investing
MT Newswires
11 days ago
SOPHiA GENETICS Partners With Precision for Medicine
PR Newswire
11 days ago
Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities
Zacks
a month ago
SOPHiA GENETICS (SOPH) Upgraded to Buy: What Does It Mean for the Stock?
PR Newswire
a month ago
SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC
Simply Wall St.
a month ago
March 2025's Promising Penny Stocks To Consider
Simply Wall St.
a month ago
SOPHiA GENETICS Full Year 2024 Earnings: In Line With Expectations
GuruFocus.com
a month ago
Sophia Genetics SA (SOPH) Q4 2024 Earnings Call Highlights: Record Customer Growth Amidst ...
Zacks
2 months ago
SOPHiA GENETICS SA (SOPH) Reports Q4 Loss, Tops Revenue Estimates
Compare SOPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SOPH SOPHiA GENETICS SA - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.